Contract Update Notices
Background: Quest Diagnostics has developed (laboratory developed test LDT) a molecular diagnostic test that aids in the diagnosis of infection of monkeypox virus in submitted specimens. This novel dual target test employs polymerase chain reaction (PCR) to aid in the qualitative detection of non-variola orthopoxviruses and monkeypox virus (West African clade) DNA, using swab specimens from patients presenting with an acute pustular or vesicular rash.
|Contractor:||Quest Diagnostics, Inc.|
|Effective Date:||Orders can be placed beginning on August 01, 2022|
|Product Name/Description, Including Assay Method & All Applicable CPT Codes||MONKEYPOX VIRUS DNA, QL, REAL TIME PCR (LDT); CPT 87593|
Delivery/Production Capacity:Quest expects to be able to perform approximately 30,000 Monkeypox virus tests a week. Depending on demand, the company can expand capacity for Monkeypox testing across other advanced laboratories within its national network.
Ordering Information: LeeAnn Bocklet - (804) 306-0913
Veterans Affairs: Normal ordering procedures are in effect.
Other Government Agencies (Federal): Please follow established local procedures.
Visit the NAC Contract Catalog Search Tool to view contract information. We will continue to work with our industry partners to add more Monkeypox tests to the FSS as expeditiously as possible. We will keep you apprised of any future updates. Please contact our FSS Helpdesk if you have any questions.
/s/Daniel H. Shearer
Director, VA Federal Supply Schedule Service